US FDA approves Ionis' drug for rare genetic disorder
US FDA approves an ionic medication for a rare genetic disorder
US FDA approves an ionic medication for a rare genetic disorder
US FDA announces a new program to enhance domestic drug production
Lechleri Croton Tree Revalled in Amazon, near Iquitos, Peru © Steven King & Nbsp Interview with: Massimo Radalli, President and Chief Executive Officer, Napo Therapeutics Massimo Radalli, PhD, is a European leader and entrepreneur of the pharmaceutical industry who has spent more than 30 years in innovation of therapies to treat rare diseases. He is … Read more
Costa Rica suspects former security minister, a former judge on drug addiction after demanding extradition to the US
Faron’s Bexmarilimab takes FDA or orphaned drug status for MDS treatment